Rightslink® by Copyright Clearance Center

Synthesis and stability test of radioimmunoconjugate 177Lu-DOTA-F(ab′)2-trastuzumab for theranostic agent of HER2 positive breast cancer

Author:

Sandra Hermanto,Ratna Dini Haryuni,Martalena Ramli,Abdul Mutalib,Sumi Hudiyono

Publication:

Journal of Radiation Research and Applied Sciences

Publisher:

Elsevier

Date:

13 October 2016

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing this content.

Note: This article is available under the Creative Commons CC-BY-NC-ND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed.

For commercial reuse, permission must be requested below.

I would like to...This drop down menu contains the options the publisher has agreed to permit for reuse of their copyrighted material. The publisher offers these types of use either directly through RightsLink or after approval by the publisher. Please reference the terms and conditions offered during the order process for a complete understanding of the use you select. Need more info?

The article selected has been excluded for permissions processing by Elsevier. It cannot be processed through RightsLink at this time.

Please submit your request by completing Elsevier’s permission request form.

You may also contact an Elsevier representative directly with any questions.

Please include the content information (article title, author, date, issn, volume, issue), a link to the content on the Web if appropriate and any details regarding your specific request.